Application 201049
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 2MG;30MG | No | No |
| 002 | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 4MG;30MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-5634 | Pioglitazone hydrochloride and glimepiride | Pioglitazone hydrochloride and glimepiride | Sandoz Inc | ANDA | Current |
| 0781-5634 | Pioglitazone hydrochloride and glimepiride | Pioglitazone hydrochloride and glimepiride | Sandoz Inc | ANDA | Current |
| 0781-5635 | Pioglitazone hydrochloride and glimepiride | Pioglitazone hydrochloride and glimepiride | Sandoz Inc | ANDA | Current |
| 0781-5635 | Pioglitazone hydrochloride and glimepiride | Pioglitazone hydrochloride and glimepiride | Sandoz Inc | ANDA | Current |